Evidence map›Paper›PMID 30662611›Full record

ArticleAmerican journal of translational research2018

MiR-378 modulates energy imbalance and apoptosis of mitochondria induced by doxorubicin.

Yu Wang, Qingshan Zhang, Chengxi Wei, Lin Zhao, Xin Guo, Xiaoxue Cui, Liqun Shao, Jie Long, Junyi Gu, Ming Zhao

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity.International journal of molecular sciences · 2022
    Review
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yu WangMedicinal Chemistry and Pharmacology Institute, Inner Mongolia University for Nationalities Tongliao, Inner Mongolia, P. R. China.
Qingshan ZhangAffiliated Hospital of Inner Mongolia University for Nationalities Tongliao, Inner Mongolia, P. R. China.
Chengxi WeiMedicinal Chemistry and Pharmacology Institute, Inner Mongolia University for Nationalities Tongliao, Inner Mongolia, P. R. China.
Lin ZhaoDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University Beijing, P. R. China.
Xin GuoMedicinal Chemistry and Pharmacology Institute, Inner Mongolia University for Nationalities Tongliao, Inner Mongolia, P. R. China.
Xiaoxue CuiMedicinal Chemistry and Pharmacology Institute, Inner Mongolia University for Nationalities Tongliao, Inner Mongolia, P. R. China.
Liqun ShaoMedicinal Chemistry and Pharmacology Institute, Inner Mongolia University for Nationalities Tongliao, Inner Mongolia, P. R. China.
Jie LongMedicinal Chemistry and Pharmacology Institute, Inner Mongolia University for Nationalities Tongliao, Inner Mongolia, P. R. China.
Junyi GuMedicinal Chemistry and Pharmacology Institute, Inner Mongolia University for Nationalities Tongliao, Inner Mongolia, P. R. China.
Ming ZhaoMedicinal Chemistry and Pharmacology Institute, Inner Mongolia University for Nationalities Tongliao, Inner Mongolia, P. R. China.
Capital Medical University · CNInner Mongolia University for Nationalities · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Doxorubicin (DOX) is an effective anticancer drug, however its clinical application is limited due to its cardiotoxicity. Therefore, understanding the mechanisms of cardiotoxicity induced by DOX is essential. We found that the level of miR-378 was decreased in the hearts of DOX-treated rats. Increasing the expression of miR-378 resulted in a decrease of lactate dehydrogenase (LDH) upon DOX treatment

Indexed as

apoptosisenergy imbalancemiR-378

Identifiers

PMID30662611
PMCPMC6291733
OpenAlexW2991019419

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.